Fierce Pharma
JULY 16, 2024
ICER has issued an access and affordability alert for Verona Pharma’s COPD drug Ohtuvayre. ICER says it is overpriced at an annual rate of $34,500.
Copyright Clearance Center
JULY 16, 2024
July 16, 2024 – Danvers, Mass. – CCC , a leader in advancing copyright, accelerating knowledge, and powering innovation, today announced the availability of artificial intelligence (AI) re-use rights within its Annual Copyright License s (ACL), an enterprise-wide content licensing solution offering rights from millions of works to businesses that subscribe.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
JULY 16, 2024
Despite a string of high-profile losses this year, at least three major drugmakers continue to fight back against the Medicare price negotiations being rolled out under the Inflation Reduction Act. | Despite a string of high-profile losses this year, at least three major drugmakers continue to fight back against the Medicare price negotiations being rolled out under the Inflation Reduction Act.
MedCity News
JULY 16, 2024
Novo Holdings led Asceneuron’s $100 million Series C financing. The Merck Serono spinout’s lead program is an oral small molecule designed to prevent aggregation of tau protein in neurodegenerative disorders. The post Tau-Focused Asceneuron Adds $100M as Oral Alzheimer’s Drug Advances to Phase 2 Trial appeared first on MedCity News.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Fierce Pharma
JULY 16, 2024
As Johnson & Johnson continues to attempt to Texas two-step its way around thousands of claims that its popular talcum powder-based products caused cancer, the drugmaker is putting up hundreds | As Johnson & Johson continues to attempt to Texas two-step its way around thousands of claims that its popular talcum powder-based products caused cancer, the drugmaker is putting up hundreds of millions of dollars to settle a longstanding dispute with a clutch of suppliers.
MedCity News
JULY 16, 2024
For the past two years, Intermountain Health has been planning to move its hospital in the Denver suburb of Wheat Ridge, Colorado about three and a half miles away to a new and updated facility. The health system is planning to complete the move in one day, using about 20 ambulances to move an estimated 180 patients. The post What Does It Take to Move an Entire Hospital in 1 Day?
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
JULY 16, 2024
As the clinical trial landscape evolves, prioritizing inclusion, innovation, and scalability is essential for accelerating the development of safe and effective treatments that truly meet the needs of diverse patient populations. The post The Triad of Inclusivity, Innovation, and Scalability: Imperatives for Today’s Clinical Trial Teams appeared first on MedCity News.
pharmaphorum
JULY 16, 2024
Novo Holdings leads $100m financing for Swiss biotech Asceneuron, which is developing an oral tau therapy for Alzheimer's disease
MedCity News
JULY 16, 2024
Seven Starling’s Series A funding round was led by RH Capital and included participation from Pear VC, Expa and Magnify Ventures. In total, the company has raised $14.3 million. The post Seven Starling Secures $10.9M To Improve Access to Women’s Mental Health appeared first on MedCity News.
pharmaphorum
JULY 16, 2024
A digital diagnostic for ADHD called QbTest should be used by the NHS as an add-on to standard assessment, says new NICE guidance
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
PharmaTimes
JULY 16, 2024
The progressive neurodegenerative condition affects around 153,000 people in the UK
pharmaphorum
JULY 16, 2024
CordenPharma has launched a €900 million ($981 million) investment programme to prepare for an expected surge in demand for peptide production capacity – driven by GLP-1 receptor agonists.The three-year plan revolves around parallel programmes in the US and Europe that will include new builds and upgrades and expansion to its existing facilities, according to the German contract development and manufacturing organisation (CDMO).
MedCity News
JULY 16, 2024
As the consent landscape continues to evolve, pediatricians are tasked with striking a careful balance – respecting the autonomy of their teenage patients while still operating within the guardrails of state regulations and parental authority. The post The Consent Conundrum Pediatricians Face appeared first on MedCity News.
pharmaphorum
JULY 16, 2024
Natural killer cell therapy specialist Artiva Biotherapeutics has another go at an IPO, hoping to raise up to $135m
Advertisement
Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten
PharmaVoice
JULY 16, 2024
An industry reeling from a precarious market is showing signs of stabilizing as the future becomes a little less cloudy, an Evaluate report suggests.
Pharmaceutical Technology
JULY 16, 2024
AstraZeneca has closed the acquisition of Amolyt Pharma, a company specialising in treatments for rare endocrine diseases.
Copyright Clearance Center
JULY 16, 2024
Copyright Clearance Center has launched a collective licensing solution for the internal use of copyrighted materials in artificial intelligence systems, with the aim of providing streamlined, legal means to use content and compensate creators.
Pharmaceutical Technology
JULY 16, 2024
Kyverna’s CEO Peter Maag said the biotech is “eager to start generating data” from a Phase II trial.
Pharmaceutical Commerce
JULY 16, 2024
The latest news for pharma industry insiders.
PharmaTimes
JULY 16, 2024
Myelodysplastic syndromes are a group of blood cancers that currently affect more than 7,000 people in the UK
Pharmaceutical Technology
JULY 16, 2024
As the EU anticipates GLP-1RA shortages throughout 2024, Corden Pharma has pledged $980m to increase manufacturing capacity.
PharmaVoice
JULY 16, 2024
The Supreme Court’s decision to overturn the Chevron doctrine would make it easier to challenge agency regulations, such as the LDT final rule.
Advertisement
Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.
Pharmaceutical Technology
JULY 16, 2024
Accounting for around 85% of lung cancer cases worldwide, non-small cell lung cancer is a key research area for clinical trials in 2024.
Pharmacy Times
JULY 16, 2024
Data presented show significant advancements in treatment options.
Contrarian Sales Techniques
JULY 16, 2024
Alex was a medical sales rep, a purveyor of hope in sleekly designed packaging. His product, a revolutionary new stent, was a marvel of engineering, a tiny titanium miracle worker. But Alex knew that dazzling doctors with technical specifications was like trying to seduce a fish with a fishing rod. What really sold was understanding the unspoken needs of the cardiac surgeon, the late-night anxieties in the emergency room, the weight of life and death hanging in the balance.
Pharmacy Times
JULY 16, 2024
Prediction model can accurately predict the risk of nerve damage in patients who received taxane-based chemotherapy.
PharmaTech
JULY 16, 2024
This event will feature a look at the crucial nexus between scientific advancement and regulatory adherence.
Pharmaceutical Commerce
JULY 16, 2024
The 50,000 square-foot facility has the ability to handle various batch sizes and dosage forms.
PharmaTech
JULY 16, 2024
The event will explore new technologies such as AI, digital twins, development approaches, CMC strategies, and regulatory frameworks, supporting rapid access to vaccines and biotherapeutics.
Pharmaceutical Technology
JULY 16, 2024
The Phase III RASolute 302 trial will compare a 300mg dose of the company’s investigational pan-RAS inhibitor RMC-6236 to chemotherapy.
Advertisement
Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A
Expert insights. Personalized for you.
307 
Let's personalize your content